Non-tuberculous mycobacterial disease in a high TB/HIV burden setting.
作者信息
Janssen S, Ismail Z, Lovelock T, Hugo S, van Schalkwyk M, Parker A, Allwood B W, Koegelenberg C F N, van Ingen J, van Laarhoven A, Mabuka T, Prozesky H, Taljaard J
机构信息
TASK, Cape Town, South Africa.
Radboud University Medical Center, Nijmegen, The Netherlands.
出版信息
IJTLD Open. 2025 Jul 9;2(7):437-439. doi: 10.5588/ijtldopen.25.0205. eCollection 2025 Jul.
Abstract
摘要
相似文献
1
Non-tuberculous mycobacterial disease in a high TB/HIV burden setting.高结核病/艾滋病负担地区的非结核分枝杆菌病
IJTLD Open. 2025 Jul 9;2(7):437-439. doi: 10.5588/ijtldopen.25.0205. eCollection 2025 Jul.
2
Sudapyridine (WX-081) antibacterial activity against , , and and .舒巴吡啶（WX-081）对 、 、 和 的抗菌活性。
mSphere. 2024 Feb 28;9(2):e0051823. doi: 10.1128/msphere.00518-23. Epub 2024 Jan 19.
3
Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay.博茨瓦纳艾滋病毒感染人群中非结核分枝杆菌的流行率高于预期：对使用Xpert MTB/RIF检测的诊断算法的影响。
PLoS One. 2017 Dec 22;12(12):e0189981. doi: 10.1371/journal.pone.0189981. eCollection 2017.
4
Prevalence and species diversity of non-tuberculous mycobacteria in North Texas.北德克萨斯非结核分枝杆菌的患病率及菌种多样性
J Infect Public Health. 2025 Oct;18(10):102890. doi: 10.1016/j.jiph.2025.102890. Epub 2025 Jul 5.
5
Increased isolation of nontuberculous mycobacteria among TB suspects in Northeastern, Tanzania: public health and diagnostic implications for control programmes.坦桑尼亚东北部结核病疑似患者中非结核分枝杆菌分离率增加：对控制项目的公共卫生及诊断意义
BMC Res Notes. 2016 Feb 17;9:109. doi: 10.1186/s13104-016-1928-3.
6
Clinical evaluation of the QuantiFERON-TB Gold test in patients with non-tuberculous mycobacterial disease.非结核分枝杆菌病患者中结核感染 T 细胞检测试剂盒（酶联免疫斑点法）的临床评价。
Int J Tuberc Lung Dis. 2009 Nov;13(11):1422-6.
7
Isolation of non-tuberculous mycobacteria among tuberculosis patients, a study from a tertiary care hospital in Lahore, Pakistan.巴基斯坦拉合尔一家三级护理医院的结核病患者中非结核分枝杆菌的分离研究。
BMC Infect Dis. 2021 Apr 24;21(1):381. doi: 10.1186/s12879-021-06086-8.
8
A prospective study of non-tuberculous mycobacterial disease among tuberculosis suspects at a tertiary care centre in north India.印度北部一家三级护理中心的结核疑似患者中非结核分枝杆菌病的前瞻性研究。
Indian J Med Res. 2019 Nov;150(5):458-467. doi: 10.4103/ijmr.IJMR_194_19.
9
[Treatment of non-tuberculous pulmonary mycobacteriosis].[非结核分枝杆菌肺病的治疗]
Kekkaku. 2006 Jan;81(1):35-50.
10
Clinical characteristics of patients with non-tuberculous mycobacterial pulmonary disease: a seven-year follow-up study conducted in a certain tertiary hospital in Beijing.非结核分枝杆菌肺病患者的临床特征：一项在北京某三甲医院进行的为期七年的随访研究。
Front Cell Infect Microbiol. 2023 Jun 22;13:1205225. doi: 10.3389/fcimb.2023.1205225. eCollection 2023.
本文引用的文献
1
Mortality and causes of death in non-tuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病的死亡率及死亡原因
Int J Tuberc Lung Dis. 2025 Feb 1;29(2):60-66. doi: 10.5588/ijtld.24.0365.
2
Challenges and knowledge gaps in the management of non-tuberculous mycobacterial pulmonary disease in sub-Saharan African countries with a high tuberculosis burden: a scoping review.高结核负担的撒哈拉以南非洲国家中非结核分枝杆菌肺病管理中的挑战和知识差距：范围综述。
BMJ Open. 2024 Jan 18;14(1):e078818. doi: 10.1136/bmjopen-2023-078818.
3
Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review.全球非结核分枝杆菌肺部感染的趋势：一项系统评价。
Int J Infect Dis. 2022 Dec;125:120-131. doi: 10.1016/j.ijid.2022.10.013. Epub 2022 Oct 13.
4
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.非结核分枝杆菌肺病的治疗：美国胸科学会/欧洲呼吸学会/欧洲临床微生物学与感染病学会/美国感染病学会官方临床实践指南
Eur Respir J. 2020 Jul 7;56(1). doi: 10.1183/13993003.00535-2020. Print 2020 Jul.
5
Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria.博茨瓦纳接受抗结核治疗的 HIV 阳性患者中非结核分枝杆菌阳性培养的结果：不使用非结核分枝杆菌诊断算法的影响。
PLoS One. 2020 Jun 12;15(6):e0234646. doi: 10.1371/journal.pone.0234646. eCollection 2020.
6
Risk factors and secondary care utilisation in a primary care population with non-tuberculous mycobacterial disease in the UK.在英国，初级保健人群中非结核分枝杆菌病的风险因素和二级保健利用情况。
Eur J Clin Microbiol Infect Dis. 2019 Jan;38(1):117-124. doi: 10.1007/s10096-018-3402-8. Epub 2018 Oct 27.
7
Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement.非结核分枝杆菌肺病的治疗结局定义：一份非结核分枝杆菌网络共识声明
Eur Respir J. 2018 Mar 22;51(3). doi: 10.1183/13993003.00170-2018. Print 2018 Mar.
8
Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort.以纤维空洞性疾病为主的非结核分枝杆菌肺病的治疗和转归。
Respir Med. 2017 Oct;131:220-224. doi: 10.1016/j.rmed.2017.08.031. Epub 2017 Sep 1.
9
Non-tuberculous Mycobacteria isolated from Pulmonary samples in sub-Saharan Africa - A Systematic Review and Meta Analyses.从撒哈拉以南非洲肺部样本中分离出的非结核分枝杆菌-系统评价和荟萃分析。
Sci Rep. 2017 Sep 20;7(1):12002. doi: 10.1038/s41598-017-12175-z.
10
Non-tuberculous mycobacteria (NTM) in Zambia: prevalence, clinical, radiological and microbiological characteristics.赞比亚的非结核分枝杆菌（NTM）：患病率、临床、放射学和微生物学特征
BMC Infect Dis. 2015 Nov 6;15:500. doi: 10.1186/s12879-015-1264-6.
Zotero 插件